Last reviewed · How we verify

NCT04255667

Eyelid Crush for Marginal Eyelid Surgery

Status unknown Last updated 27 January 2021
What this trial tests

trial testing Eyelid margin crush in Eyelid Diseases in 60 participants. Status unknown.

Timeline
1 January 2019
Primary endpoint
1 April 2021
15 April 2021

Quick facts

Lead sponsorBenha University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date1 January 2019
Primary completion1 April 2021
Estimated completion15 April 2021
Sites1 location across United Arab Emirates

Drugs / interventions tested

Conditions studied

Sponsor

Benha University

Who can join

Adults 18 to 70, any sex, with Eyelid Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgery involves eyelid margin asscocited with intraoperative bleeding. Proper intra-operative homeostasis is essential for good intraoperative procedure and postoperative results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Eyelid Diseases

Currently open trials in the same condition.

Other Benha University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04255667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing